Robert N. Shapiro’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$648K Sell
6,872
-1,665
-20% -$172K 0.13% 152
2014
Q3
$909K Buy
8,537
+755
+10% +$73.9K 0.17% 140
2014
Q2
$646K Buy
7,782
+1,105
+17% +$86K 0.12% 157
2014
Q1
$473K Buy
6,677
+333
+5% +$26.1K 0.09% 184
2013
Q4
$477K Sell
6,344
-275
-4% -$19.1K 0.09% 186
2013
Q3
$417K Buy
6,619
+1,654
+33% +$98.9K 0.07% 188
2013
Q2
$254K Buy
+4,965
New +$259K 0.05% 236

Other funds holding GILD

Robert N. Shapiro's GILD Position: Q4 2014 in Review

Robert N. Shapiro reduced its Gilead Sciences (GILD) stake by 20% in Q4 2014, selling an estimated $172K and leaving 6,872 shares worth $648K. The position accounts for 0.13% of the portfolio, ranked #152.

Robert N. Shapiro first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. The position peaked at $909K in Q3 2014. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Robert N. Shapiro held 6,872 shares of Gilead Sciences worth $648K as of Q4 2014.
  • Robert N. Shapiro sold 1,665 Gilead Sciences shares in Q4 2014, an estimated $172K.
  • Gilead Sciences made up 0.13% of Robert N. Shapiro's portfolio in Q4 2014, its #152 holding.
  • Robert N. Shapiro first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Gilead Sciences position peaked at $909K in Q3 2014.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.